| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.12 | 8e-05 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.35 | 0.0006 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |